Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm.
Shibuya
M
M
Chukyo Hospital, Nagoya, Tokyo, Japan.
Asano
T
T
Sasaki
Y
Y
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000818:Animals; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007269:Injections, Intra-Arterial; D047428:Protein Kinase Inhibitors; D020301:Vasospasm, Intracranial / Q000188:drug therapy*
D004791:Enzyme Inhibitors; D047428:Protein Kinase Inhibitors; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; C049347:fasudil